6242 Stock Overview
Manufactures and sells supplement, cosmeceutical, and hygienic drink products. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Li Kang Biomedical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$43.15 |
| 52 Week High | NT$61.60 |
| 52 Week Low | NT$42.60 |
| Beta | 0.26 |
| 11 Month Change | -2.04% |
| 3 Month Change | -0.80% |
| 1 Year Change | -22.95% |
| 33 Year Change | 35.33% |
| 5 Year Change | 30.91% |
| Change since IPO | -85.58% |
Recent News & Updates
Recent updates
Li Kang Biomedical (GTSM:6242) Has Some Way To Go To Become A Multi-Bagger
Apr 19
Is Li Kang Biomedical Co., Ltd. (GTSM:6242) A Smart Choice For Dividend Investors?
Mar 09Li Kang Biomedical Co., Ltd.'s (GTSM:6242) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Feb 09The Trends At Li Kang Biomedical (GTSM:6242) That You Should Know About
Jan 19We Think Li Kang Biomedical (GTSM:6242) Can Stay On Top Of Its Debt
Dec 29Three Things You Should Check Before Buying Li Kang Biomedical Co., Ltd. (GTSM:6242) For Its Dividend
Dec 08Shareholder Returns
| 6242 | TW Personal Products | TW Market | |
|---|---|---|---|
| 7D | -0.6% | -4.3% | -3.4% |
| 1Y | -22.9% | -17.8% | 30.2% |
Return vs Industry: 6242 underperformed the TW Personal Products industry which returned -17.8% over the past year.
Return vs Market: 6242 underperformed the TW Market which returned 30.2% over the past year.
Price Volatility
| 6242 volatility | |
|---|---|
| 6242 Average Weekly Movement | 1.9% |
| Personal Products Industry Average Movement | 3.7% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in TW Market | 8.0% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 6242 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 6242's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1982 | 122 | n/a | www.likangbio.com |
Li Kang Biomedical Co., Ltd. manufactures and sells supplement, cosmeceutical, and hygienic drink products. It also engages in the management and consulting of tourism factory business; and offers telemarketing services. The company was formerly known as BAFO Technologies Corporation and changed its name to Li Kang Biomedical Co., Ltd.
Li Kang Biomedical Co., Ltd. Fundamentals Summary
| 6242 fundamental statistics | |
|---|---|
| Market cap | NT$1.37b |
| Earnings (TTM) | NT$81.99m |
| Revenue (TTM) | NT$573.36m |
16.7x
P/E Ratio2.4x
P/S RatioIs 6242 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6242 income statement (TTM) | |
|---|---|
| Revenue | NT$573.36m |
| Cost of Revenue | NT$180.61m |
| Gross Profit | NT$392.75m |
| Other Expenses | NT$310.76m |
| Earnings | NT$81.99m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.58 |
| Gross Margin | 68.50% |
| Net Profit Margin | 14.30% |
| Debt/Equity Ratio | 4.2% |
How did 6242 perform over the long term?
See historical performance and comparison